Stock A084110 HUONS GLOBAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Huons Global Co., Ltd.

Equities

A084110

KR7084110006

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-22 pm EDT 		5-day change 1st Jan Change
21,550 KRW +0.47% Intraday chart for Huons Global Co., Ltd. +0.70% -8.88%
Mar. 20 Huons Global Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Huons Global Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Huons Global Co., Ltd., formerly, Huons Co., Ltd. is Kore-based entity principally engaged in the manufacture and distribution of pharmaceutical products. Along with its subsidiaries, the Company operates its business through two segments: pharmaceutical segment and glass container segment. The pharmaceutical segment produces pharmaceutical products including parenteral injections such as lidocaines, merit C injections; tablets such as phentermines, diet pills and others; capsules such as Daisen and Fuxetine and other ethical and over-the-counter drugs. The glass container segment produces ampoules, vials, cartridges and caps for used of medicals, foods and cosmetics. The Company also manufactures medical devices such as kits, derma injectors and other injector.

Number of employees: 116

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceuticals
114.1 %
758,519 114.2 % 864,960 114.1 % +14.03%
Elimination of Internal Trade
-19.4 %
-127,085 -19.1 % -147,144 -19.4 % +15.78%
Holding Company
5.2 %
32,931 5.0 % 39,328 5.2 % +19.42%
Meal Kit
0.2 %
- - 1,236 0.2 % -

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
664,365 100.0 % 758,380 100.0 % +14.15%

Managers

Managers TitleAgeSince
Sung-Tae Yoon CEO
 Chief Executive Officer 59 -
Bo-Young Yun PSD
 President 59 -
Wan-Seob Kim BRD
 Director/Board Member 60 17-03-16
Jong-Jeong Lee AUD
 Comptroller/Controller/Auditor 70 19-03-14
Yung-Mok Kim PRN
 Corporate Officer/Principal 54 -
Kyung-Ah Kim PRN
 Corporate Officer/Principal 60 -

Members of the board

Members of the board TitleAgeSince
Sung-Tae Yoon CEO
 Chief Executive Officer 59 -
Bo-Young Yun PSD
 President 59 -
Wan-Seob Kim BRD
 Director/Board Member 60 17-03-16
Gyu-Rae Lee BRD
 Director/Board Member 62 19-03-14
Byeong-Hoon Tak BRD
 Director/Board Member 66 17-03-16
Gyu-Yeon Lee BRD
 Director/Board Member 60 22-03-30
Jin-Woo Jang BRD
 Director/Board Member 65 22-03-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 12,621,492 5,031,042 ( 39.86 %) 373,417 ( 2.959 %) 39.86 %

Shareholders

NameEquities%Valuation
Sung-Tae Yoon
43.84 %
5,533,011 43.84 % 94 M ₩
In-Sang Yoon
4.156 %
524,594 4.156 % 9 M ₩
Kyung-Ah Kim
3.404 %
429,692 3.404 % 7 M ₩
HUONS GLOBAL CO., LTD.
2.959 %
373,417 2.959 % 6 M ₩
Yeon-sang Yoon
2.738 %
345,585 2.738 % 6 M ₩
Hee-sang Yoon
2.539 %
320,506 2.539 % 5 M ₩
Huno Lab Co., Ltd.
0.5913 %
74,628 0.5913 % 1 M ₩
State Street Global Advisors Ltd.
0.0722 %
9,118 0.0722 % 155 438 ₩
Dimensional Fund Advisors Ltd.
0.0486 %
6,128 0.0486 % 104 466 ₩
DFA Australia Ltd.
0.0187 %
2,364 0.0187 % 40 300 ₩

Holdings

NameEquities%Valuation
HUONS CO., LTD.
40.74%
 4,880,709 40.74% 127,433,164 $
HUMEDIX CO., LTD.
36.08%
 4,051,873 36.08% 86,831,233 $
HUONS GLOBAL CO., LTD.
2.96%
 373,417 2.96% 6,365,770 $
BFLYSOFT., LTD
1.53%
 480,000 1.53% 508,080 $

Company contact information

Huons Global Co., Ltd.

Unit C-901, Pangyo Innovalley 253 Pangyo-ro

13486, Seongnam-si

+

http://www.huonsglobal.com
address Huons Global Co., Ltd.(A084110)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
HUONS GLOBAL CO., LTD. Stock Huons Global Co., Ltd.
-8.88% 191M
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+12.05% 9.18B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-16.33% 4.78B
YUHAN CORPORATION Stock Yuhan Corporation
+6.40% 3.87B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+26.98% 3.73B
INDIVIOR PLC Stock Indivior PLC
+28.27% 2.52B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-26.55% 2.27B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-25.02% 2.21B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+5.82% 1.95B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A084110 Stock
  4. Company Huons Global Co., Ltd.